Cargando…
Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study
Experimental studies suggest ceramides may play a role in insulin resistance. However, the relationships of circulating ceramides and related sphingolipids with plasma insulin have been underexplored in humans. We measured 15 ceramide and sphingomyelin species in fasting baseline samples from the St...
Autores principales: | Lemaitre, Rozenn N., Yu, Chaoyu, Hoofnagle, Andrew, Hari, Nair, Jensen, Paul N., Fretts, Amanda M., Umans, Jason G., Howard, Barbara V., Sitlani, Colleen M., Siscovick, David S., King, Irena B., Sotoodehnia, Nona, McKnight, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054436/ https://www.ncbi.nlm.nih.gov/pubmed/29588286 http://dx.doi.org/10.2337/db17-1449 |
Ejemplares similares
-
Circulating sphingolipids, fasting glucose, and impaired fasting glucose: The Strong Heart Family Study
por: Jensen, Paul N., et al.
Publicado: (2018) -
Epigenome-Wide Association Study of Fasting Measures of Glucose, Insulin, and HOMA-IR in the Genetics of Lipid Lowering Drugs and Diet Network Study
por: Hidalgo, Bertha, et al.
Publicado: (2014) -
Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study
por: Jensen, Paul N., et al.
Publicado: (2022) -
Plasma ceramides containing saturated fatty acids are associated with risk of type 2 diabetes
por: Fretts, Amanda M., et al.
Publicado: (2021) -
Plasma sphingolipids, lung function and COPD: the Cardiovascular Health Study
por: Gharib, Arya R., et al.
Publicado: (2023)